Offstream
news

Changes

1. Trials for the drug developed by Novavax is shown to be 90% effective against COVID-19 and the Lineage B.1.1.7 variant of SARS-CoV-2.
   2021-03-31 03:06:19 (First version)
2. Trials for the drug developed by Novavax show that it is 90% effective against COVID-19 and the Lineage B.1.1.7 variant of SARS-CoV-2.
   2021-03-31 11:06:11 (Update)
3. Trials for the Novavax COVID-19 vaccine show that it is 90% effective against COVID-19 and the Lineage B.1.1.7 variant of SARS-CoV-2.
   (Current version)

Related